Capillary leak syndrome likely the result of granulocyte colony-stimulating factor after high-dose chemotherapy

Intern Med. 1994 Feb;33(2):115-9. doi: 10.2169/internalmedicine.33.115.

Abstract

Two cases of malignant lymphoma complicated with capillary leak syndrome following super high-dose chemotherapy and administration of granulocyte colony-stimulating factor (G-CSF) are presented. Subsequent to the nadir of granulocytes, and at the stage of rapid increase of granulocytes, the symptoms of fever, hypotension, dyspnea, pleural effusion and edema appeared, and laboratory data revealed hypoxia, hypocapnia and hypoalbuminemia. In addition, an abscess-like lesion was observed in the liver in one patient. After the administration of G-CSF was ceased or decreased, and pulse therapy with methylprednisolone was initiated, these symptoms disappeared quickly.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Bone Marrow Transplantation
  • Capillary Permeability / drug effects*
  • Combined Modality Therapy
  • Edema / chemically induced*
  • Edema / complications
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / therapy
  • Male
  • Neutropenia / chemically induced
  • Neutropenia / therapy*
  • Spinal Cord Neoplasms / drug therapy
  • Syndrome
  • Tonsillar Neoplasms / complications
  • Tonsillar Neoplasms / drug therapy
  • Tonsillar Neoplasms / therapy

Substances

  • Immunologic Factors
  • Granulocyte Colony-Stimulating Factor